2022
DOI: 10.1093/ehjqcco/qcac024
|View full text |Cite
|
Sign up to set email alerts
|

Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study

Abstract: Background Population studies reporting contemporary long-term outcomes following catheter ablation of atrial fibrillation (AF) are sparse. Objective To evaluate long-term clinical outcomes following AF ablation and examine variation in outcomes by age, sex, and the presence of heart failure. Methods and Results We identified 30,601 unique patients (mean age … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Nevertheless, ablation is invasive and is associated with a clinically significant risk of early complications [16]. Moreover, about half of patients undergoing AF ablation have recurrence of AF of sufficient severity to warrant rehospitalization over time; thus, this is not a cure or replacement for pharmacological therapy [17]. Furthermore, anticoagulation reduces but does not eliminate the embolic risk of AF [6] and is associated with a risk of bleeding [18].…”
Section: Limitations Of Current Treatmentmentioning
confidence: 99%
“…Nevertheless, ablation is invasive and is associated with a clinically significant risk of early complications [16]. Moreover, about half of patients undergoing AF ablation have recurrence of AF of sufficient severity to warrant rehospitalization over time; thus, this is not a cure or replacement for pharmacological therapy [17]. Furthermore, anticoagulation reduces but does not eliminate the embolic risk of AF [6] and is associated with a risk of bleeding [18].…”
Section: Limitations Of Current Treatmentmentioning
confidence: 99%
“…Atrial fibrillation (AF) is the terminal ordinary endpoint of atrial remodeling attributable to multiple cardiac diseases and is a prominent contributor to cardiovascular morbidity and mortality [ 7 ]. Although the development of AF ablation techniques has created more alternatives for AF treatment, investigations have highlighted that nearly 50% of patients still demand repeat ablation [ 8 ]. Nowadays, the pathogenesis of AF has not been thoroughly elaborated, so it is pivotal to explore the underlying mechanism to prevent and manage it.…”
Section: Introductionmentioning
confidence: 99%